Bayer CropScience Ltd Q2 FY26 results (latest), Jul–Sep 2025 →Revenue ₹1,553 Cr −10.6% YoYSee revenue, profit and what management said. You are viewing Q4 FY21.
BC

Bayer CropScience Ltd

Q4 FY21Fertilizers & Agrochemicals

Bayer CropScience Q4 FY21 earnings call: Revenue & Margins

Q4 FY21 investor presentation: what the company reported on revenue, margins and capex.

Bayer CropScience Ltd Q4 FY21 key numbers

Revenue
Q4 2020-21 Revenue from Operations: ₹7,337 million, up 60% YoY.

As stated in Bayer CropScience Ltd's Q4 FY21 investor presentation · published 24 Sept 2026. Reported figures, not investment advice.

Based on Bayer CropScience Ltd's Q4 FY21 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.

Price₹3,736
Market cap₹17.0K Cr
P/E23.2

The short version

Q4 2020-21 Revenue from Operations: ₹7,337 million, up 60% YoY (Page 10) - Q4 2020-21 Profit Before Exceptional Items and Tax: ₹735 million, up 20% YoY (Page 10) - Full Year (FY) 2020-21 Revenue f Q4 EBITDA before exceptional items: ₹7,337 million, up 20% YoY (Page 10) - Q4 Revenue from operations: ₹42,613 million, up 18% YoY (Page 10) - Q4 Profit Before Exceptional Items and Tax: ₹7,894 mi

From Bayer CropScience Ltd's Q4 FY21 earnings-call transcript · updated 24 Sept 2026.

Revenue & Sales Performance

- Q4 2020-21 Revenue from Operations: ₹7,337 million, up 60% YoY (Page 10) - Q4 2020-21 Profit Before Exceptional Items and Tax: ₹735 million, up 20% YoY (Page 10) - Full Year (FY) 2020-21 Revenue from Operations: ₹42,613 million, up 18% YoY (Page 10) - FY 2020-21 Profit Before Exceptional Items and Tax: ₹7,894 million, up 11% YoY (Page 10) - Crop Science segment Q1 2021 sales: €12,328 million, +3% adjusted for currency and portfolio effects (Page 8) - EBITDA before Special items Q1 2021: €4,118 million, down 6% (Page 8) Explicit Outlook:

2 more points from Bayer CropScience Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Bayer CropScience Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

No direct references to capital expenditure, capacity expansion plans, or new project investments are included in the slides from pages 1 to 21.

Top-ranked in Fertilizers & Agrochemicals

Ranked on what management guided this quarter

Guidance-ranked
1Anya Polytech &
Rev 2Mar 1
Rev 2Mar 2
3
Rev 2Mar 3
4
Rev 2Mar 3
5
Rev 3Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Bayer CropScience Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The following relevant points are mentioned: - Growth in Crop Protection driven by Vegetables, Rice & Apple and pre-orders of Roundup (RUP) (Page 16). - Importance of on-time & last-mile availability at retail points this season, with limited opportunity for amendments (Page 15).

2 more points from Bayer CropScience Ltd's call on order book

Create a free account to keep reading this call

Bayer CropScience Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26

Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹1.1K Cr, net profit ₹162 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Bayer CropScience Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Bayer CropScience Ltd Q4 FY21 results?

Q4 2020-21 Revenue from Operations: ₹7,337 million, up 60% YoY (Page 10) - Q4 2020-21 Profit Before Exceptional Items and Tax: ₹735 million, up 20% YoY (Page 10) - Full Year (FY) 2020-21 Revenue f Q4 EBITDA before exceptional items: ₹7,337 million, up 20% YoY (Page 10) - Q4 Revenue from operations: ₹42,613 million, up 18% YoY (Page 10) - Q4 Profit Before Exceptional Items and Tax: ₹7,894 mi

What is Bayer CropScience Ltd share price analysis?

Bayer CropScience Ltd currently shows a neutral. The stock trades at a P/E of 23.2 with a market cap of ₹16,986 Cr. Investors should review the full earnings analysis for detailed insights.

Keep Bayer CropScience Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.